Weighted Average Number of Shares Outstanding, Basic of Neuphoria Therapeutics Inc. from 30 Jun 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Neuphoria Therapeutics Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2023 to 31 Dec 2025.
  • Neuphoria Therapeutics Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 4,536,235, a 188% increase year-over-year.
  • Neuphoria Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 1,622,924, a 95% increase from 2024.
  • Neuphoria Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 832,225, a 43% decline from 2023.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Neuphoria Therapeutics Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 4,536,235 +2,960,991 +188% 01 Oct 2025 31 Dec 2025 10-Q 17 Feb 2026 2025 Q2
Q3 2025 2,246,066 +946,001 +73% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q1
Q2 2025 1,622,924 +790,699 +95% 01 Apr 2025 30 Jun 2025 10-K 29 Sep 2025 2025 FY
Q1 2025 1,719,073 +738,033 +75% 01 Jan 2025 31 Mar 2025 10-Q 20 May 2025 2025 Q3
Q4 2024 1,575,244 +717,980 +84% 01 Oct 2024 31 Dec 2024 10-Q 17 Feb 2026 2025 Q2
Q3 2024 1,300,065 -195,930 -13% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q1
Q2 2024 832,225 01 Apr 2024 30 Jun 2024 10-K 29 Sep 2025 2025 FY
Q1 2024 981,040 01 Jan 2024 31 Mar 2024 10-Q 20 May 2025 2025 Q3
Q4 2023 857,264 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2025 2025 Q2
Q3 2023 1,495,995 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2025 Q1

Neuphoria Therapeutics Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 1,622,924 +790,699 +95% 01 Jul 2024 30 Jun 2025 10-K 29 Sep 2025 2025 FY
2024 832,225 -636,510 -43% 01 Jul 2023 30 Jun 2024 10-K 29 Sep 2025 2025 FY
2023 1,468,735 01 Jul 2022 30 Jun 2023 10-K 30 Sep 2024 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.